Joseph Ndika1, Liisa Airaksinen2, Hille Suojalehto2, Piia Karisola1, Nanna Fyhrquist1, Anne Puustinen3, Harri Alenius4. 1. Department of Bacteriology and Immunology, Medicum, University of Helsinki, Helsinki, Finland. 2. Occupational Medicine, Finnish Institute of Occupational Health, Helsinki, Finland. 3. Department of Clinical Chemistry, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. 4. Department of Bacteriology and Immunology, Medicum, University of Helsinki, Helsinki, Finland; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: Harri.Alenius@ki.se.
Abstract
BACKGROUND: Seasonal allergic rhinitis (SAR) caused by intermittent exposure to seasonal pollen causes itching, nasal congestion, and repeated sneezing, with profound effects on quality of life, work productivity, and school performance. Although both the genotype and environmental factors can contribute to the immunologic basis of allergic reactions, the molecular underpinnings associated with the pathogenesis of allergic rhinitis are not entirely clear. METHODS: To address these questions, nasal epithelial brushings were collected from 29 patients with SAR and 31 control subjects during and after the pollen season. We then implemented an orbitrap-based, bottom-up, label-free quantitative proteomics approach, followed by multivariate analyses to identify differentially abundant (DA) proteins among the 4 sample groups. RESULTS: We identified a total of 133 DA proteins for which the most significantly overrepresented functional category was found to be interferon 1 signaling. Two proteins, cystatin 1 and myeloblastin, the former of which protects against protease activity of allergens and the latter with a role in epithelial barrier function, were DA in patients with SAR and control subjects, irrespective of season. Moreover, interferon-inducible protein with tetratricopeptide repeats 1, cystatin 1, and interferon-inducible protein with tetratricopeptide repeats 3 were found to be differentially regulated between patients with SAR and control subjects, with inverse abundance dynamics during the transition from fall to spring. CONCLUSION: We identified type 1 interferon-regulated proteins as biomarkers in patients with SAR, potentially playing an important role in its pathogenesis. Moreover, when compared with patients with SAR, healthy subjects exhibit an antagonistic proteomic response across seasons, which might prove to be a therapeutic target for disease prevention.
BACKGROUND:Seasonal allergic rhinitis (SAR) caused by intermittent exposure to seasonal pollen causes itching, nasal congestion, and repeated sneezing, with profound effects on quality of life, work productivity, and school performance. Although both the genotype and environmental factors can contribute to the immunologic basis of allergic reactions, the molecular underpinnings associated with the pathogenesis of allergic rhinitis are not entirely clear. METHODS: To address these questions, nasal epithelial brushings were collected from 29 patients with SAR and 31 control subjects during and after the pollen season. We then implemented an orbitrap-based, bottom-up, label-free quantitative proteomics approach, followed by multivariate analyses to identify differentially abundant (DA) proteins among the 4 sample groups. RESULTS: We identified a total of 133 DA proteins for which the most significantly overrepresented functional category was found to be interferon 1 signaling. Two proteins, cystatin 1 and myeloblastin, the former of which protects against protease activity of allergens and the latter with a role in epithelial barrier function, were DA in patients with SAR and control subjects, irrespective of season. Moreover, interferon-inducible protein with tetratricopeptide repeats 1, cystatin 1, and interferon-inducible protein with tetratricopeptide repeats 3 were found to be differentially regulated between patients with SAR and control subjects, with inverse abundance dynamics during the transition from fall to spring. CONCLUSION: We identified type 1 interferon-regulated proteins as biomarkers in patients with SAR, potentially playing an important role in its pathogenesis. Moreover, when compared with patients with SAR, healthy subjects exhibit an antagonistic proteomic response across seasons, which might prove to be a therapeutic target for disease prevention.
Authors: Juan Carlos Vizuet-de-Rueda; Josaphat Miguel Montero-Vargas; Miguel Ángel Galván-Morales; Raúl Porras-Gutiérrez-de-Velasco; Luis M Teran Journal: Int J Mol Sci Date: 2022-05-20 Impact factor: 6.208
Authors: Ulrika Käck; Elisabet Einarsdottir; Marianne van Hage; Anna Asarnoj; Anna James; Anna Nopp; Kaarel Krjutškov; Shintaro Katayama; Juha Kere; Gunnar Lilja; Cilla Söderhäll; Jon R Konradsen Journal: ERJ Open Res Date: 2021-04-19
Authors: Andres Cardenas; Joanne E Sordillo; Sheryl L Rifas-Shiman; Wonil Chung; Liming Liang; Brent A Coull; Marie-France Hivert; Peggy S Lai; Erick Forno; Juan C Celedón; Augusto A Litonjua; Kasey J Brennan; Dawn L DeMeo; Andrea A Baccarelli; Emily Oken; Diane R Gold Journal: Nat Commun Date: 2019-07-12 Impact factor: 14.919
Authors: Lasse Ruokolainen; Nanna Fyhrquist; Tiina Laatikainen; Petri Auvinen; Vittorio Fortino; Giovanni Scala; Pekka Jousilahti; Piia Karisola; Johanna Vendelin; Antti Karkman; Olga Markelova; Mika J Mäkelä; Sari Lehtimäki; Joseph Ndika; Noora Ottman; Laura Paalanen; Lars Paulin; Erkki Vartiainen; Leena von Hertzen; Dario Greco; Tari Haahtela; Harri Alenius Journal: Clin Exp Allergy Date: 2020-09-18 Impact factor: 5.018